Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Core Viewpoint - Absci Corporation (NASDAQ: ABSI) has experienced a significant decline in investor confidence, with shares dropping to just above $2, nearing its 52-week low since February 2025 [1] Company Summary - Absci Corporation's stock has seen a notable decrease in value, reflecting a loss of confidence among investors [1]